Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin.
As more people with end stage renal disease are treated with erythropoietin for their anaemia, a well-coordinated system is essential to monitor their response to treatment. This is best achieved by keeping management of the system in the hands of one or two people.